Edwards Lifesciences Corporation (EW)

NYSE: EW · IEX Real-Time Price · USD

85.94

-0.51 (-0.59%)

At close: Apr 19, 2024, 4:00 PM

86.00

+0.06 (0.07%)

After-hours: Apr 19, 2024, 7:02 PM EDT

Edwards Lifesciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1997
Cash & Equivalents	1,144	769	862.8	1,183	1,179	714.1	818.3	930.1	718.4	653.8	Upgrade
Short-Term Investments	500.5	446.3	604	219.4	337.8	242.4	519.2	341	506.3	785	Upgrade
Cash & Cash Equivalents	1,645	1,215	1,467	1,403	1,517	956.5	1,338	1,271	1,225	1,439	Upgrade
Cash Growth	35.32%	-17.15%	4.58%	-7.54%	58.59%	-28.49%	5.22%	3.79%	-14.88%	53.57%	Upgrade
Receivables	836.9	699.1	664.9	602.8	599.1	537.3	479.3	414.6	371.8	330.8	Upgrade
Inventory	1,168	875.5	726.7	802.3	640.9	607	554.9	396.6	339.9	296.8	Upgrade
Other Current Assets	386.1	305.9	322.3	283.3	227.1	186.1	177.5	157.7	111.5	164.7	Upgrade
Total Current Assets	4,036	3,096	3,181	3,091	2,984	2,287	2,549	2,240	2,048	2,231	Upgrade
Property, Plant & Equipment	1,843	1,725	1,639	1,489	1,140	867.5	679.7	580	482.5	442.9	Upgrade
Long-Term Investments	583.9	1,239	1,834	801.6	585.5	506.3	567	532.1	379.9	240.9	Upgrade
Goodwill and Intangibles	1,682	1,450	1,492	1,505	1,504	1,455	1,595	830.9	833.7	399.4	Upgrade
Other Long-Term Assets	1,218	783.1	357.5	350.5	274	207.6	276	327	312.3	208.7	Upgrade
Total Long-Term Assets	5,328	5,197	5,322	4,146	3,504	3,037	3,117	2,270	2,008	1,292	Upgrade
Total Assets	9,363	8,293	8,503	7,237	6,488	5,324	5,666	4,510	4,056	3,523	Upgrade
Accounts Payable	1,171	996.9	1,007	866.7	876.9	876.6	770.3	532.5	476.2	426.1	Upgrade
Current Debt	24.9	25.5	25.5	27.2	25.5	0	598	0	0	0	Upgrade
Other Current Liabilities	0	0	0	0	0	0	51.7	0	0	0	Upgrade
Total Current Liabilities	1,195	1,022	1,032	893.9	902.4	876.6	1,420	532.5	476.2	426.1	Upgrade
Long-Term Debt	670	665.8	664.8	667.7	653.3	593.8	438.4	822.3	596.9	598.1	Upgrade
Other Long-Term Liabilities	778.4	797.6	969.6	1,101	784.1	712.9	851.8	536.2	480.1	307.4	Upgrade
Total Long-Term Liabilities	1,448	1,463	1,634	1,769	1,437	1,307	1,290	1,359	1,077	905.5	Upgrade
Total Liabilities	2,644	2,486	2,667	2,663	2,340	2,183	2,710	1,891	1,553	1,332	Upgrade
Total Debt	694.9	691.3	690.3	694.9	678.8	593.8	1,036	822.3	596.9	598.1	Upgrade
Debt Growth	0.52%	0.14%	-0.66%	2.37%	14.31%	-42.71%	26.04%	37.76%	-0.20%	0.84%	Upgrade
Retained Earnings	8,992	7,590	6,068	4,565	3,742	2,695	1,962	3,906	3,337	2,842	Upgrade
Comprehensive Income	-242.8	-254.9	-157.7	-161.1	-156	-138.5	-132.7	-198.4	-182.6	-100.9	Upgrade
Shareholders' Equity	6,650	5,807	5,836	4,574	4,148	3,140	2,956	2,619	2,503	2,191	Upgrade
Net Cash / Debt	949.6	524	776.5	707.7	838.1	362.7	301.1	448.8	627.8	840.7	Upgrade
Net Cash / Debt Growth	81.22%	-32.52%	9.72%	-15.56%	131.07%	20.46%	-32.91%	-28.51%	-25.32%	144.53%	Upgrade
Net Cash Per Share	1.56	0.84	1.23	1.12	1.32	0.57	0.46	0.69	0.95	1.29	Upgrade
Working Capital	2,840	2,073	2,148	2,197	2,082	1,410	1,129	1,708	1,572	1,805	Upgrade
Book Value Per Share	10.96	9.38	9.36	7.35	6.64	5.00	4.67	4.10	3.87	3.43	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).